Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Urogenital Neoplasms × abemaciclib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 17 Neoplasm Metastasis 5 Urogenital Neoplasms 1 Unilateral Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1

Interventions

padeliporfin 2 valrubicin 1 temsirolimus 1 palladium-bacteriopheophorbide 1 abiraterone 1 abemaciclib 1 Standard of Care 1 Prednisone 1 Prednisolone 1 Drug Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05288166 2025-06-27

CYCLONE 3

Eli Lilly and Company

Phase 3 Active not recruiting

925 enrolled 12 charts

Neoplasm Metastasis, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡